Archive
-
CleanTech reports Laguna Verde progress, revises results for ASX listing
Tue 31 December 2024 11:14
(Sharecast News) - CleanTech Lithium, a company focused on lithium exploration and development in Chile, updated the market on its application for a special lithium operating contract (CEOL) for the Laguna Verde project on Tuesday, as well as its amended -
Hummingbird refinances Coris loans with $35.6m borrowing
Tue 31 December 2024 11:10
(Sharecast News) - Hummingbird Resources announced the signing of a $35.6m loan agreement on Tuesday, to support the cash flow needs of its Malian subsidiary, Société des Mines de Komana (SMK). -
ValiRx further extends letter of intent with TheoremRx
Tue 31 December 2024 11:07
(Sharecast News) - ValiRx, a life science company specialising in early-stage cancer therapeutics and women's health, announced a further amendment to its letter of intent with TheoremRx regarding the proposed sub-license of VAL201 on Tuesday. -
Zephyr Energy receives $7.5m to fully finance well drilling and testing
Tue 31 December 2024 08:59
(Sharecast News) - Zephyr Energy confirmed the receipt of $7.5m in funds to fully finance the drilling, completion, and production testing of the extended lateral on its State 36-2 LNW-CC-R well on Tuesday. -
Arecor upbeat on signing of exclusive licensing deal
Mon 30 December 2024 10:05
(Sharecast News) - Arecor Therapeutics announced the signing of an exclusive licensing agreement for AT351, a ready-to-dilute (RTD) liquid formulation of a widely-used critical care therapy, with a subsidiary of a leading global pharmaceutical-focused che -
Ondine enrols first patient in phase three clinical trial
Mon 30 December 2024 10:02
(Sharecast News) - Ondine Biomedical announced the launch of its phase three clinical trial for 'light-activated antimicrobial therapy to prevent surgical site infections' (LANTERN) on Monday, having enrolled its first patient. -
Ondine enrols first patient in phase three clinical trial
Mon 30 December 2024 10:02
(Sharecast News) - Ondine Biomedical announced the launch of its phase three clinical trial for 'light-activated antimicrobial therapy to prevent surgical site infections' (LANTERN) on Monday, having enrolled its first patient. -
SDX Energy shares surge as it delays general meeting
Mon 30 December 2024 09:57
(Sharecast News) - SDX Energy shares were surging on Monday, after it announced the postponement of its general meeting. -
Proton Motor Power to slash costs, delist from AIM
Mon 30 December 2024 09:54
(Sharecast News) - Zero-carbon fuel cell and hybrid systems developer Proton Motor Power announced plans to operate on a significantly reduced cost basis on Monday, while pursuing the cancellation of its shares from trading on AIM. -
Duke Capital flags another rise in recurring cash revenue
Mon 30 December 2024 09:50
(Sharecast News) - Hybrid business capital specialist Duke Capital said in a trading update on Monday that it anticipated recurring cash revenue of £6.5m for its third quarter, marking a 4% increase compared to £6.3m in the same period in the 2024 finan -
Thruvision appoints finance chief as its new CEO
Mon 30 December 2024 08:34
(Sharecast News) - Walk-through security technology specialist Thruvision Group announced the appointment of its chief financial officer, Victoria Balchin, as its new chief executive officer on Monday, effective 2 January. -
Helix Exploration agrees to acquire helium processing plant
Mon 30 December 2024 07:24
(Sharecast News) - Helix Exploration, a company focused on helium exploration and development within the Montana Helium Fairway, announced on Monday that it has entered into a letter of intent to acquire a helium pressure swing adsorption (PSA) processing -
Gelion confident after reporting narrower EBITDA loss
Fri 27 December 2024 12:55
(Sharecast News) - Energy storage technology company Gelion reported total income of £2m in its final results on Friday, primarily from research and development tax incentives and grant income, consistent with market expectations. -
Rome Resources receives subscription funds from Stanvic
Fri 27 December 2024 12:50
(Sharecast News) - Democratic Republic of the Congo-focussed tin explorer Rome Resources announced the receipt of subscription funds from Stanvic on Friday, as part of its strategic investment initiative. -
Genedrive upbeat on publication of clinical performance data
Fri 27 December 2024 12:27
(Sharecast News) - Point-of-care pharmacogenetic testing specialist Genedrive announced on Friday that clinical performance data for its Genedrive CYP2C19-ID Kit had been published in the Journal of Molecular Biology. -
Two killed in further unrest near Gemfields Mozambique venture
Fri 27 December 2024 07:13
(Sharecast News) - Gemfields updated the market on the unrest in Mozambique on Thursday, reporting two deaths as "illegal" ruby mining groups exploited ongoing political instability. -
Electric Guitar becomes cash shell as subsidiary enters liquidation
Tue 24 December 2024 12:14
(Sharecast News) - Electric Guitar confirmed on Tuesday that 3radical, previously its primary operating subsidiary, had entered creditors' voluntary liquidation following shareholder and creditor approval on 23 December. -
Mindflair raises £0.49m through share placing
Tue 24 December 2024 12:12
(Sharecast News) - Next-generation artificial intelligence specialist Mindflair announced on Tuesday that it has raised £0.49m through a share placing. -
Roadside Real Estate swings to full-year profit
Tue 24 December 2024 12:06
(Sharecast News) - Roadside Real Estate reported a profit after tax of £43.2m in its final results on Tuesday, a significant swing from the prior year's £10.2m loss, largely driven by discontinued operations, including a £41m non-cash gain from the par -
Power Metal deal to buy into GSAe reaches second phase
Tue 24 December 2024 11:58
(Sharecast News) - Power Metal Resources updated the market on its agreement to acquire a 75% stake in GSA Environmental (GSAe) on Tuesday - an engineering technology firm specialising in industrial waste remediation and metal extraction.